Home › Trials › NCT06207032

A biobank registry platform for cancer patients

TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

Observational Tempus AI · NCT06207032

This study is testing how blood samples from cancer patients can help researchers learn more about tumor DNA and improve cancer treatments.

Quick facts

Study typeObservational
Enrollment500 (estimated)
Ages18 Years to 99 Years
SexAll
SponsorTempus AI Industry-sponsored
Locations32 sites (Birmingham, Alabama and 31 other locations)
Trial IDNCT06207032 on ClinicalTrials.gov

What this trial studies

This observational study evaluates cancer patients who will undergo longitudinal profiling of circulating tumor DNA (ctDNA) biomarkers alongside their standard care treatments. It is a multicenter and multicohort study designed to gather data on ctDNA to better understand its role in oncology. Participants will provide blood samples at specific time points to facilitate this biomarker analysis, contributing to a biobank registry that may enhance future cancer research.

Who should consider this trial

Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with cancer and are willing to participate.

Not a fit: Patients who are not willing or able to provide additional blood samples will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could improve personalized treatment strategies for cancer patients by utilizing ctDNA profiling.

How similar studies have performed: Other studies utilizing ctDNA profiling in oncology have shown promising results, indicating potential for success in this approach.

Eligibility criteria

Show full inclusion / exclusion criteria 
Inclusion Criteria:

1. ≥18 years of age
2. Willing to participate in the research
3. Able to provide informed consent
4. Must be diagnosed with cancer

Exclusion Criteria:

1\. Not willing or able to have additional blood samples collected

Where this trial is running

Birmingham, Alabama and 31 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov → Find more trials like this →
Conditions CancerctDNANext-Generation SequencingOncology
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.